NURTEC ODT
NDC 72618-3001, rimegepant sulfate, tablet, orally disintegrating, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 72618-3001
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212728
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72618-3001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIMEGEPANT SULFATE75 mg/1
Pharmacologic classes
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72618-3001-2 | 72618300102 | 4 DOSE PACK in 1 CARTON (72618-3001-2) / 1 BLISTER PACK in 1 DOSE PACK (72618-3001-1) / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| 72618-3001-4 | 72618300104 | 1 BLISTER PACK in 1 CARTON (72618-3001-4) / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9ef08e09-1098-35cc-e053-2a95a90a3e1d
Use it
Look up 72618-3001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72618-3001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72618-3001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.